approval
saveTYENNE (TOCILIZUMAB-AAZG) — FDA approval
community read0 votes
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 7
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalMay 12, 2025 · 508d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalMar 13, 2025 · 568d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalFeb 28, 2025 · 581d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalDec 13, 2024 · 658d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalDec 3, 2024 · 668d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalSep 5, 2024 · 757d ago
- approvalTYENNE (TOCILIZUMAB-AAZG) — FDA approvalMar 5, 2024 · 941d ago
same company · ±60 days · 6
- approvalGLYCOPYRROLATE — FDA approvalJan 19, 2026
- approvalGLYCOPYRROLATE — FDA approvalJan 19, 2026
- approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalJan 15, 2026
- device 510kFresenius Kabi AG — KabiHelp® Uno; KabiHelp® Advance plus (510k cleared)Jan 9, 2026
- approvalEfudex: FLUOROURACIL — FDA approvalFeb 5, 2026
- approvalEfudex: FLUOROURACIL — FDA approvalFeb 5, 2026
comments(0)
5-min edit window · permanent after that